Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases.
about
A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing SpondylitisRORγ antagonists and inverse agonists: a patent review.Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders.Selective Interleukin-23 p19 Inhibition: Another Game Changer in Psoriasis? Focus on Risankizumab.New treatment options and emerging drugs for axial spondyloarthritis: biological and targeted synthetic agents.Arthritis models: usefulness and interpretation.Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease.The role of IL 23 in the treatment of psoriasis.Functional Implications of the IL-23/IL-17 Immune Axis in Schizophrenia.Interleukin 17 is a chief orchestrator of immunity.Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis.HMGB1-TLR4-IL23-IL17A axis promotes paraquat-induced acute lung injury by mediating neutrophil infiltration in mice.Brief Report: Group 3 Innate Lymphoid Cells in Human Enthesis.Transcriptional signature of human pro-inflammatory TH17 cells identifies reduced IL10 gene expression in multiple sclerosis.Th17 and Treg lymphocytes as cellular biomarkers of disease activity in Granulomatosis with Polyangiitis.Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis.Shifting the Focus: The Primary Role of IL-23 in Psoriasis and other Inflammatory Disorders.Recipient mucosal-associated invariant T cells control GVHD within the colon.Economic Burden Can Be the Major Determining Factor Resulting in Short-Term Intermittent and Repetitive Ustekinumab Treatment for Moderate-to-Severe Psoriasis.Andrographolide presents therapeutic effect on ulcerative colitis through the inhibition of IL-23/IL-17 axis.The role of secukinumab in the treatment of psoriatic arthritis and ankylosing spondylitis
P2860
Q28069331-64AC8EDC-F799-4540-90CF-D5BC2785B9ACQ34540327-30C11841-0B2A-4F9B-B8E3-183C0AB6DF74Q38632657-EDA33066-3229-4F8E-940F-01FE65883636Q38645111-E5F51228-E1EC-40A1-B6B3-BFC4F76EE68FQ38768900-6E33D06E-1D8B-4A58-9925-E07002444239Q38872112-17BEB247-A8D7-4A81-A521-0D0D620AC710Q38923185-1DA42FED-7DC2-4D92-8038-5098E5C52E1BQ38976762-896300EE-C6AE-41CB-8AB6-3232C1E849FFQ39024232-4D30C8DB-2827-405D-B517-78EFCB1F51CDQ39314776-DA3EFC5C-3E0A-4363-B464-041AB34998D2Q39356029-72F587BA-0C8B-4435-A85A-853AF103DFFCQ42035297-530544ED-0D89-4DCE-BB4C-229E23B07A91Q46154278-32906D59-8F27-49CB-AB5C-B5CF701F08BEQ47155991-667CB0C6-402D-43B1-8E68-02D3AD9E4F2BQ47925876-616FB853-D7D6-4F4E-88A7-A1684B74E4C4Q48148502-CEFAE314-3663-47CF-8BCC-B1BF5EEAA380Q50041283-61A2352C-3B88-4D1A-A101-6D031736A6CEQ54239585-F713A612-020C-4BC0-97B3-C00802D107FDQ55193949-03DE97F6-9F0A-4C11-83E4-EAFB44E53BC2Q55284143-791D6499-4152-44A5-9DFB-4D3FB55EAD0EQ58761666-67949C77-8594-48D7-8938-407C54FB167D
P2860
Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases.
@en
type
label
Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases.
@en
prefLabel
Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases.
@en
P1476
Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases.
@en
P2093
Iain B McInnes
P304
P356
10.1146/ANNUREV-MED-051914-021944
P577
2015-11-04T00:00:00Z